Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2133 (LINC02133) is a human gene that gives rise to a long intergenic non-coding RNA (lincRNA), a subclass of long non-coding RNAs (lncRNAs) that are located between protein-coding genes and do not encode proteins[1][3]. LincRNAs such as LINC02133 can have various roles in cellular biology, including modulation of chromatin structure, gene expression, and potentially acting as scaffolds or regulators at the RNA level[3]. However, the specific functions, disease implications, interactions, and clinical relevance of LINC02133 remain largely uncharacterized. There is no evidence to date of LINC02133 serving as a drug target, diagnostic biomarker, or being implicated in any human disease[1][3].
Not applicable; there are no known drugs or therapies targeting LINC02133
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2133 (LINC02133).